`

Phanes Therapeutics, Inc

Biotechnology Research

Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$40.0M
size-icon Size
11 - 50
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About Phanes Therapeutics, Inc

What does Phanes therapeutics, inc do?+

Phanes Therapeutics, Inc. is a clinical stage biotech company focused on innovative drug discovery and development in oncology. Currently, it is conducting three Phase I clinical trials, including the MORNINGSTAR study with its best-in-class monoclonal antibody (mAb) program, PT199, the TWINPEAK study with PT886 and the SKYBRIDGE study with PT217. Both PT886 and PT217 are first-in-class bispecific antibodies and have been granted orphan drug designation as well as Fast Track designation by the FDA. The company has built a strong pipeline by leveraging its proprietary technology platforms: PACbody, SPECpair and ATACCbody to develop novel biologics that address high unmet medical...

What is Phanes therapeutics, inc's industry? +

Phanes therapeutics, inc operates in the Biotechnology research industry.

What is Phanes therapeutics, inc's revenue? +

Phanes therapeutics, inc's revenue is 11m - 100m

What is Phanes therapeutics, inc's company size? +

Phanes therapeutics, inc has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free